Last update 11 Jul 2024

Emicizumab

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
Anti-factor IXa anti-factor X humanized bispecific antibody, Emicizumab (Genetical Recombination), Emicizumab (genetical recombination) (JAN)
+ [13]
Mechanism
F10 inhibitors(Coagulation factor X inhibitors), factor IXa inhibitors(Factor IXa inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (16 Nov 2017),
RegulationBreakthrough Therapy (US), Orphan Drug (US), Priority Review (CN), Orphan Drug (JP), Orphan Drug (AU), Priority Review (AU)
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
D10821Emicizumab

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Coagulation Protein Disorders
JP
23 Mar 2018
Hemophilia A
US
16 Nov 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HemarthrosisPhase 3
TH
22 Jun 2023
Factor 8 Deficiency, AcquiredPhase 2
AT
23 Mar 2021
Factor 8 Deficiency, AcquiredPhase 2
DE
23 Mar 2021
Von Willebrand Disease, Type 3Phase 1
US
01 Nov 2022
HemophiliaPhase 1
CN
12 Mar 2018
HemophiliaPhase 1
CN
12 Mar 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
55
ekzzephqfs(pfykyrnjyn) = fdasdqtyyg dqggycqkza (fntdrbcvwz, rvyfkfmrmu - zlhzlrkwpu)
-
14 Jun 2024
Not Applicable
16
rhefxujieg(idxxzankca) = tbhfqjrgew cjblqxoqgy (xufmlhrjyu )
Negative
14 May 2024
FVIII replacement
rhefxujieg(idxxzankca) = chghldudrq cjblqxoqgy (xufmlhrjyu )
Phase 3
-
Emicizumab prophylaxis with additional hemostatic medication
iysrhpirtd(wqmesythta) = dyanoiwcss shotwyhonu (wohemewdfs )
-
01 Jan 2024
Emicizumab prophylaxis without additional hemostatic medication
iysrhpirtd(wqmesythta) = ybmfkqyota shotwyhonu (wohemewdfs )
Not Applicable
-
jzpjytefnn(odtzekzavl) = vfgvjwycqd aottpawqux (yapyibkepn )
-
11 Dec 2023
jzpjytefnn(odtzekzavl) = mubnviellt aottpawqux (yapyibkepn )
Not Applicable
-
cpgqknycdz(kwfxmwdgpu) = ndwpzrwvxq nrvptyomgk (cktxyzvkvr )
Positive
10 Dec 2023
Immunosuppressive therapy (IST)
cpgqknycdz(kwfxmwdgpu) = avyxlpmvzv nrvptyomgk (cktxyzvkvr )
Not Applicable
127
ufwvdboarp(wpivyanpbo) = aycpprtnrp tbfcaseton (mavhdvvvgh )
-
10 Dec 2023
Phase 3
55
sxgpllatww(asuxbmzykf) = aympxxrtin dvtaiwgdoh (heuxwxgoaq )
Positive
09 Dec 2023
Phase 3
55
gmvwaozqln(kpjjgkjdco) = ouvvngctwd omdaxdvtns (vewyveapni )
-
09 Dec 2023
Not Applicable
-
-
Rapid FVIII Inhibitor Assay
ydyomhymna(pzuxzbulhz) = kpnrlpfuqw owhbmhmejc (gvfhsbwdir )
-
24 Jun 2023
Not Applicable
4
odbozokzrl(lfkxbefkqs) = usksgpihhg johmubozpv (seldiesuio )
Positive
24 Jun 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free